Full name
INSTYTUT BADAWCZO - ROZWOJOWY "BIOGENED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
20.42.Z - Manufacture of cosmetics and toilet preparations
46.45.Z - Wholesale trade of perfumes and cosmetics
47.75.Z - Retail sale of cosmetics and toiletries
72.1 - Scientific research and development in natural and technical sciences
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1 | 1 | 3,1 | 225,7 |
Gross profit (loss) | 1 | 0,7 | 3,1 | 347,1 |
EBITDA | 1 | 0,7 | 3,1 | 352,6 |
Short time liabilities | 4,5 | 4,9 | 3,8 | -22,5 |
Other operating costs | 0 | 0,3 | 0 | -99,3 |
Equity capital | 1,6 | 1,7 | 5,2 | 205,8 |
Operating profit (EBIT) | 1 | 0,7 | 3,1 | 352,6 |
Assets | 6,1 | 7,6 | 10,1 | 31,5 |
Net profit (loss) | 0,9 | 0,6 | 2,9 | 347,2 |
Cash | 0,1 | 0,1 | 0,6 | 360,9 |
Net income from sale | 1,4 | 1,6 | 4 | 154,3 |
Liabilities and provisions for liabilities | 4,5 | 5,9 | 4,8 | -18,5 |
Working assets | 6,1 | 5,4 | 7,8 | 44,6 |
Other income costs | 0 | 0 | 0 | -∞ |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 54,4 | 37,6 | 55 | 17,4 |
Equity capital to total assets | 26,9 | 22,3 | 51,8 | 29,5 |
Gross profit margin | 68,3 | 45,2 | 79,5 | 34,3 |
EBITDA Margin | 68,4 | 44,5 | 79,3 | 34,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 1132 | 1143 | 348 | -795 |
Current financial liquidity indicator | 1.3581793308258057 | 1.1067414283752441 | 2.0658719539642334 | 1 |
Net dept to EBITDA | -0.12632979452610016 | -0.1921803206205368 | -0.19572106003761292 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane